BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3002979)

  • 1. Renal and systemic effects of enalapril in chronic one-kidney hypertension.
    Woods RL; Anderson WP; Korner PI
    Hypertension; 1986 Feb; 8(2):109-16. PubMed ID: 3002979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs.
    Selig SE; Anderson WP; Korner PI; Casley DJ
    J Hypertens; 1983 Aug; 1(2):153-8. PubMed ID: 6099382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in the hypertension induced by renal artery stenosis.
    Anderson WP; Selig SE; Korner PI
    Clin Exp Hypertens A; 1984; 6(1-2):299-314. PubMed ID: 6697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog.
    Anderson WP; Johnston CI; Korner PI
    J Physiol; 1979 Feb; 287():231-45. PubMed ID: 219182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of stenosis resistance to the rise in total peripheral resistance during experimental renal hypertension in conscious dogs.
    Anderson WP; Korner PI; Angus JA; Johnston CI
    Clin Sci (Lond); 1981 Dec; 61(6):663-70. PubMed ID: 7028365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs.
    Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
    Am J Physiol; 1997 Dec; 273(6):R1980-9. PubMed ID: 9435652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal actions of angiotensin II in renovascular hypertension.
    Anderson WP; Woods RL; Denton KM; Alcorn D
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1559-65. PubMed ID: 3690389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
    J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
    Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
    Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs.
    Anderson WP; Shweta A; Evans RG; Edgley AJ; Gao Y
    J Hypertens; 2007 Mar; 25(3):649-62. PubMed ID: 17278982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced slow pressor effect of angiotensin II in two-kidney, one clip rats.
    Melaragno MG; Fink GD
    Hypertension; 1995 Feb; 25(2):288-93. PubMed ID: 7843781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin II in renal wrap hypertension.
    Denton KM; Anderson WP
    Hypertension; 1985; 7(6 Pt 1):893-8. PubMed ID: 3000937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
    Bagby SP; Fuchs EF
    Hypertension; 1989 Feb; 13(2):91-101. PubMed ID: 2536643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.